TY - JOUR
T1 - A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency
AU - Yamaguchi, Rie
AU - Kato, Fumiko
AU - Hasegawa, Tomonobu
AU - Katsumata, Noriyuki
AU - Fukami, Maki
AU - Matsui, Toshiharu
AU - Nagasaki, Keisuke
AU - Ogata, Tsutomu
PY - 2013
Y1 - 2013
N2 - Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by primary hypocortisolism and normal mineralocorticoid production. Recently, NNT encoding the nicotinamide nucleotide transhydrogenase has been identified as a causative gene for FGD. Thus, we examined NNT in six Japanese FGD patients with no recognizable mutation in the previously known four responsible genes for FGD (MC2R, MRAP, STAR, and MCM4), and identified a novel homozygous substitution (c.644T>C; p.Phe215Ser) in a single 17.5-year-old boy. His parents were heterozygous for this mutation. This substitution was absent from 120 Japanese control subjects and was not registered in public databases including JSNP Database. The phenylalanine residue at the 215th codon was evolutionally conserved, and the p.Phe215Ser was assessed to be a pathologic mutation by in silico protein function analyses. The results, in conjunction with the previous data, imply that NNT mutations account for 5-10% of FGD patients, and that underlying factor(s) still remains to be clarified in a substantial fraction of FGD patients.
AB - Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by primary hypocortisolism and normal mineralocorticoid production. Recently, NNT encoding the nicotinamide nucleotide transhydrogenase has been identified as a causative gene for FGD. Thus, we examined NNT in six Japanese FGD patients with no recognizable mutation in the previously known four responsible genes for FGD (MC2R, MRAP, STAR, and MCM4), and identified a novel homozygous substitution (c.644T>C; p.Phe215Ser) in a single 17.5-year-old boy. His parents were heterozygous for this mutation. This substitution was absent from 120 Japanese control subjects and was not registered in public databases including JSNP Database. The phenylalanine residue at the 215th codon was evolutionally conserved, and the p.Phe215Ser was assessed to be a pathologic mutation by in silico protein function analyses. The results, in conjunction with the previous data, imply that NNT mutations account for 5-10% of FGD patients, and that underlying factor(s) still remains to be clarified in a substantial fraction of FGD patients.
KW - Familial glucocorticoid deficiency
KW - In silico functional analysis
KW - NNT
UR - http://www.scopus.com/inward/record.url?scp=84880944060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880944060&partnerID=8YFLogxK
U2 - 10.1507/endocrj.EJ13-0024
DO - 10.1507/endocrj.EJ13-0024
M3 - Article
C2 - 23474776
AN - SCOPUS:84880944060
SN - 0918-8959
VL - 60
SP - 855
EP - 859
JO - Endocrine journal
JF - Endocrine journal
IS - 7
ER -